AgmaSet(R) - Gilad&Gilad Rebrand their Leading Supplement for Nerve Pain-free Functions

AgmaSet® (Neurofencine(TM)) - New brand name for Gilad&Gilad's exclusive nutraceutical supplement for nerve pain-free functions containing the neuroprotective ingredient G-agmatine®.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
It is estimated that more than 20 million people in the United States alone cope everyday with circumstances that pose threat to normal nerve functions.

Los Angeles, California (PRWEB) April 13, 2012

Gilad&Gilad announced that its novel first-of-its-kind nutraceutical supplement for nerve pain-free functions is now rebranded AgmaSet®, previously known as Neurofencine(TM).*†

AgmaSet® is a more distinctive, shorter and easier to pronounce name. According to the company's CEO, Dr. Gad M. Gilad, "many customers, including healthcare professionals and their patients, expressed difficulties in pronouncing Neurofencine. AgmaSet® associates with the name of the neuroprotective ingredient G-agmatine® (Gilad&Gilad's exclusive brand of agmatine) and is suggestive of the need to set nerve functions with AgmaSet®."

"It is estimated that more than 20 million people in the United States alone cope everyday with circumstances that pose threat to normal nerve functions".

AgmaSet® is highly effective for pain-free nerve functions not only in humans, but also for animals and therefore, is marketed for veterinary use and for companion animals under the brand name AgmaVet(TM). The recently launched product has already garnered large following for the one simple reason - it works.

AgmaSet® was developed based on the discovery of the neuroprotective properties of G-agmatine®, a naturally occurring metabolite of the amino acid arginine. This breakthrough discovery, made and patented by the company's neuroscientist founders, was substantiated by extensive worldwide scientific research. G-agmatine® is present in small amounts in plant, fish and meat foodstuffs. In high amounts, it acts as a shotgun targeting multiple molecular mechanisms critical for healthy nerve functions including: key neurotransmitters; potassium and calcium ion channels; molecule membrane transporters; nitric oxide (NO) production; polyamine metabolism; and extracellular proteins.

Recent clinical trials, published in Pain Medicine (Pain Med. 11: 356–368, 2010), demonstrate the safety and effectiveness of G-agmatine® for pain-free nerve functions and for promoting health-related quality of life. These studies provide a 'proof of concept' for using AgmaSet®, which contains high amounts of G-agmatine®, as a general solution for effectively promoting healthy and pain-free nerve functions.

An overview of these landmark findings and of further clinical studies was recently presented at the American Academy of Pain Medicine 28th Annual Meeting (February 24th, 2012, Palm Spring, California). According to the authors, "these studies demonstrate that compared to current standards, dietary G-agmatine® is safer and more efficacious for promoting nerve cell survival (i.e., neuroprotection) and healthier axonal function (i.e., axonoprotection).To exert its beneficial effects, G-agmatine® may interact with multiple molecular mechanisms that become compromised not only as a result of harsh physical conditions (e.g., proper spine-nerve structure/function relationships critical for pain-free sciatic nerve functions), but also as a typical consequence of drastic changes in metabolic functions (e.g., glucose metabolism), environmental insults (e.g., toxic chemicals), heredity and other conditions which pose threats to normal nerve functions."

Thus, AgmaSet® by fortifying the diet with high effective amounts of G-agmatine®, affords nerve pain-free functions, normal sensory functions and nerve-dependent muscle strength. AgmaSet®, therefore, has wide implications for multitude of people worldwide whose need for a dietary supplement, which can afford a safe and effective alternative for nerve resilience and nerve pain-free functions, remained unmet until now.

AgmaSet® is manufactured in the USA under the highest quality standards and regulations and is available only from Gilad&Gilad. - Providing novel, safe and more effective products of superior quality backed by solid scientific and clinical evidence is the 'Gilad&Gilad's Principle' that earns the trust of healthcare professionals and gaining credibility with the public.

AgmaSet® is presently, sold direct to consumers online, to practicing healthcare professionals, to pharmacies, health stores, and to distributors. Further information and product discounts can be found on the Company's website: http://www.ForNerveHealth.com. For wholesale discounts and for business opportunities, please contact Gilad&Gilad directly.

About Gilad&Gilad
Gilad&Gilad LLC is an innovative, privately owned company in Reseda (Los Angeles), California, with a mission to providing safer and more effective products of superior quality for healthier and resilient nervous system functions. It was founded in 2000 by Dr. Gad Gilad and Varda Gilad following years of collaborative scientific research and based on their breakthrough discovery of the neuroprotective properties of G-agmatine®, Gilad&Gilad's trademarked brand of agmatine. The Company builds its reputation on continuous investment in solid scientific research and sound clinical studies, thus earning the trust of health care professionals and gaining credibility with the public. - For further information about Gilad&Gilad please visit http://www.ForNerveHealth.com.

  • The language used in this Press Release conforms to all relevant FDA and FTC regulations.
† The statements in this Press Release have not been evaluated by the Food and Drug Administration. The Products mentioned in this Press Release are not intended to diagnose, treat, cure, or prevent any disease.

CONTACT INFORMATION:
Gad M. Gilad, Ph.D.
CEO, Gilad&Gilad LLC
Phone: 1-818-708-8505
Email: gmg(at)GiladandGilad(dot)com; URL: http://www.ForNerveHealth.com


Contact

  • Gad Gilad

    323-599-0774
    Email

Attachments